Effects of Aldosterone on Chemerin Expression And Secretion in 3T3-L1 Adipocytes

被引:5
作者
Ma, Junhua [1 ]
Sun, Fei [1 ]
Wang, Jingnan [1 ]
Jiang, He [2 ]
Lu, Jiancan [1 ]
Wang, Xing [1 ]
Zhang, Jichen [1 ]
Shi, Chao [1 ]
You, Wen [1 ]
Li, Xiangqi [1 ]
Zhu, Hongling [1 ]
Gu, Mingjun [1 ]
机构
[1] Second Mil Med Univ, Shanghai Gongli Hosp, Dept Endocrinol, Miaopu Rd 219, Shanghai 200135, Peoples R China
[2] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
aldosterone; chemerin; 3T3-L1; adipocyte; metabolic syndrome; cardiovascular disease; CORONARY-ARTERY-DISEASE; MINERALOCORTICOID RECEPTOR; METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN SENSITIVITY; ADIPONECTIN; DYSFUNCTION; INFLAMMATION; RESISTANCE; BLOCKADE;
D O I
10.1055/s-0043-118749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aldosterone plays a pivotal role in the pathogenesis of metabolic syndrome and cardiovascular disease; however, the underlying mechanisms have not been clarified. Chemerin has been characterized as an adipokine with crucial roles in obesity-associated disorders and cardiovascular homeostasis. The aim of the present study was to investigate the direct effects of aldosterone on chemerin expression and secretion in 3T3-L1 adipocytes and to identify the potential signalling pathways involved. Chemerin mRNA levels were measured using real-time PCR, whereas the levels of secreted chemerin in the culture media were determined using ELISA. Treatment with aldosterone induced time- and dose-dependent increases of chemerin gene expression and protein secretion, and effect that was mediated through the mineralocorticoid receptor. Signalling studies suggested that the NF-B pathway is involved in aldosterone-induced chemerin expression. Taken together, our data demonstrate a direct interaction between aldosterone and chemerin in adipocytes, which may be an underlying mechanism linking aldosterone-associated metabolic abnormalities and cardiovascular disease.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 40 条
  • [21] Adipokines and Cardiometabolic Profile in Primary Hyperaldosteronism
    Iacobellis, Gianluca
    Petramala, Luigi
    Cotesta, Dario
    Pergolini, Mario
    Zinnamosca, Laura
    Cianci, Rosario
    De Toma, Giorgio
    Sciomer, Susanna
    Letizia, Claudio
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) : 2391 - 2398
  • [22] Chemerin as an independent predictor of cardiovascular event risk
    Inci, Sinan
    Aksan, Gokhan
    Dogan, Pinar
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2016, 7 (02) : 57 - 68
  • [23] Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension
    Irita, J
    Okura, T
    Manabe, S
    Kurata, M
    Miyoshi, K
    Watanabe, S
    Fukuoka, T
    Higaki, J
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (03) : 293 - 297
  • [24] Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome
    Jialal, Ishwarlal
    Devaraj, Sridevi
    Kaur, Harmeet
    Adams-Huet, Beverley
    Bremer, Andrew A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03) : E514 - E517
  • [25] Aldosterone directly affects apelin expression and secretion in adipocytes
    Jiang, He
    Ye, Xiao-Ping
    Yang, Zhong-Yin
    Zhan, Ming
    Wang, Hai-Ning
    Cao, Huang-Min
    Xie, Hui-Jun
    Pan, Chun-Ming
    Song, Huai-Dong
    Zhao, Shuang-Xia
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 51 (01) : 37 - 48
  • [26] Interleukin-1β induces the novel adipokine chemerin in adipocytes in vitro
    Kralisch, Susan
    Weise, Sebastian
    Sommer, Grit
    Lipfert, Jana
    Lossner, Ulrike
    Bluher, Matthias
    Stumvoll, Michael
    Fasshauer, Mathias
    [J]. REGULATORY PEPTIDES, 2009, 154 (1-3) : 102 - 106
  • [27] Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes
    Kraus, D
    Jäger, J
    Meier, B
    Fasshauer, M
    Klein, J
    [J]. HORMONE AND METABOLIC RESEARCH, 2005, 37 (07) : 455 - 459
  • [28] Aldosterone and metabolic syndrome is increased aldosterone in metabolic syndrome patients an additional risk factor?
    Krug, Alexander W.
    Ehrhart-Bornstein, Monika
    [J]. HYPERTENSION, 2008, 51 (05) : 1252 - 1258
  • [29] Aldosterone Perturbs Adiponectin and PAI-1 Expression and Secretion in 3T3-L1 Adipocytes
    Li, P.
    Zhang, X. -N.
    Pan, C. -M.
    Sun, F.
    Zhu, D. -L.
    Song, H. -D.
    Chen, M. -D.
    [J]. HORMONE AND METABOLIC RESEARCH, 2011, 43 (07) : 464 - 469
  • [30] Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes
    Li, RY
    Song, HD
    Shi, WJ
    Hu, SM
    Yang, YS
    Tang, JF
    Chen, MD
    Chen, JL
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2004, 33 (01) : 11 - 19